Your browser doesn't support javascript.
loading
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Shibamiya, Asuka; Miyamoto-Nagai, Yurie; Koide, Shuhei; Oshima, Motohiko; Rizq, Ola; Aoyama, Kazumasa; Nakajima-Takagi, Yaeko; Kato, Rei; Kayamori, Kensuke; Isshiki, Yusuke; Oshima-Hasegawa, Nagisa; Muto, Tomoya; Tsukamoto, Shokichi; Takeda, Yusuke; Koyama-Nasu, Ryo; Chiba, Tetsuhiro; Honda, Hiroaki; Yokote, Koutaro; Iwama, Atsushi; Sakaida, Emiko; Mimura, Naoya.
Afiliação
  • Shibamiya A; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Miyamoto-Nagai Y; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Koide S; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Oshima M; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Rizq O; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Aoyama K; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakajima-Takagi Y; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kato R; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kayamori K; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Isshiki Y; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Oshima-Hasegawa N; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Muto T; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Tsukamoto S; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
  • Takeda Y; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Koyama-Nasu R; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Chiba T; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Honda H; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yokote K; Department of Experimental-Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Iwama A; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Sakaida E; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Mimura N; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Cancer Immunol Immunother ; 72(8): 2635-2648, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37069353
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão